Abstract
Alterations in several specific enzymes have been associated with increased rates of purine synthesis de novo in human and other mammalian cells. However, these recognized abnormalities in humans account for only a few percent of the clinical cases of hyperuricemia and gout. We have examined in detail the rates of purine production de novo and purine excretion by normal and by mutant (AU-100) murine lymphoma T cells (S49) 80% deficient in adenylosuccinate synthetase [IMP:L-aspartate ligase (GDP-forming), EC 6.3.4.4]. The intracellular ATP concentration of the mutant cells is slightly diminished, but their GTP is increased 50% and their IMP, four-fold. Compared to wild-type cells, the AU-100 cells excrete into the culture medium 30- to 50-fold greater amounts of purine metabolites consisting mainly of inosine. Moreover, the AU-100 cell line overproduces total purines. In an AU-100-derived cell line, AU-TG50B, deficient in adenylosuccinate synthetase and hypoxanthine/guanine phosphoribosyltransferase (IMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.8), purine nucleoside excretion is increased 50- to 100-fold, and de novo synthesis is even greater than that for AU-100 cells. The overexcretion of purine metabolites by the AU-100 cells seems to be due to the primary genetic deficiency of adenylosuccinate synthetase, a deficiency that requires the cell to increase intracellular IMP in an attempt to maintain ATP levels. As a consequence of elevated IMP pools, large amounts of inosine are secreted into the culture medium. We propose that a similar primary genetic defect may account for the excessive purine excretion in some patients with dominantly inherited hyperuricemia and gout.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Becker M. A., Kostel P. J., Meyer L. J., Seegmiller J. E. Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2749–2752. doi: 10.1073/pnas.70.10.2749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Becker M. A., Meyer L. J., Wood A. W., Seegmiller J. E. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity. Science. 1973 Mar 16;179(4078):1123–1126. doi: 10.1126/science.179.4078.1123. [DOI] [PubMed] [Google Scholar]
- Becker M. A., Raivio K. O., Bakay B., Adams W. B., Nyhan W. L. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions. J Clin Invest. 1980 Jan;65(1):109–120. doi: 10.1172/JCI109640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan T. S., Ishii K., Long C., Green H. Purine excretion by mammalian cells deficient in adenosine kinase. J Cell Physiol. 1973 Jun;81(3):315–322. doi: 10.1002/jcp.1040810304. [DOI] [PubMed] [Google Scholar]
- Coffino P., Baumal R., Laskov R., Scharff M. D. Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol. 1972 Jun;79(3):429–440. doi: 10.1002/jcp.1040790313. [DOI] [PubMed] [Google Scholar]
- Cohen A., Doyle D., Martin D. W., Jr, Ammann A. J. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med. 1976 Dec 23;295(26):1449–1454. doi: 10.1056/NEJM197612232952603. [DOI] [PubMed] [Google Scholar]
- Fox I. H., Kelley W. N. Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition. J Biol Chem. 1972 Apr 10;247(7):2126–2131. [PubMed] [Google Scholar]
- Gordon R. B., Thompson L., Johnson L. A., Emmerson B. T. Regulation of purine de novo synthesis in cultured human fibroblasts: the role of P-ribose-PP. Biochim Biophys Acta. 1979 Mar 28;562(1):162–176. doi: 10.1016/0005-2787(79)90135-7. [DOI] [PubMed] [Google Scholar]
- Green C. D., Martin D. W., Jr Characterization of a feedback-resistant phosphoribosylpyrophosphate synthetase from cultured, mutagenized hepatoma cells that overproduce purines. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3698–3702. doi: 10.1073/pnas.70.12.3698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Green H., Ishii K. On the existence of a guanine nucleotide trap, the role of adenosine kinase and a possible cause of excessive purine production in mammalian cells. J Cell Sci. 1972 Jul;11(1):173–177. doi: 10.1242/jcs.11.1.173. [DOI] [PubMed] [Google Scholar]
- Gudas L. J., Cohen A., Ullman B., Martin D. W., Jr Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells. Somatic Cell Genet. 1978 Mar;4(2):201–219. doi: 10.1007/BF01538985. [DOI] [PubMed] [Google Scholar]
- Hershfield M. S., Seegmiller J. E. Regulation of de novo purine synthesis in human lymphoblasts. Similar rates of de novo synthesis during growth by normal cells and mutants deficient in hypoxanthine-guanine phosphoribosyltransferase activity. J Biol Chem. 1977 Sep 10;252(17):6002–6010. [PubMed] [Google Scholar]
- Holmes E. W., McDonald J. A., McCord J. M., Wyngaarden J. B., Kelley W. N. Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties. J Biol Chem. 1973 Jan 10;248(1):144–150. [PubMed] [Google Scholar]
- Horibata K., Harris A. W. Mouse myelomas and lymphomas in culture. Exp Cell Res. 1970 Apr;60(1):61–77. doi: 10.1016/0014-4827(70)90489-1. [DOI] [PubMed] [Google Scholar]
- Kelley W. N., Greene M. L., Rosenbloom F. M., Henderson J. F., Seegmiller J. E. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Intern Med. 1969 Jan;70(1):155–206. doi: 10.7326/0003-4819-70-1-155. [DOI] [PubMed] [Google Scholar]
- Khym J. X. An analytical system for rapid separation of tissue nucleotides at low pressures on conventional anion exchangers. Clin Chem. 1975 Aug;21(9):1245–1252. [PubMed] [Google Scholar]
- LIEBERMAN I. Enzymatic synthesis of adenosine-5'-phosphate from inosine-5'-phosphate. J Biol Chem. 1956 Nov;223(1):327–339. [PubMed] [Google Scholar]
- Lever J. E., Nuki G., Seegmiller J. E. Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2679–2683. doi: 10.1073/pnas.71.7.2679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MAGASANIK B., MOYED H. S., GEHRING L. B. Enzymes essential for the biosynthesis of nucleic acid guanine; inosine 5'-phosphate dehydrogenase of Aerobacter aerogenes. J Biol Chem. 1957 May;226(1):339–350. [PubMed] [Google Scholar]
- Martin D. W., Jr, Owen N. T. Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture. J Biol Chem. 1972 Sep 10;247(17):5477–5485. [PubMed] [Google Scholar]
- Rosenbloom F. M., Henderson J. F., Caldwell I. C., Kelley W. N., Seegmiller J. E. Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem. 1968 Mar 25;243(6):1166–1173. [PubMed] [Google Scholar]
- Seegmiller J. E., Rosenbloom F. M., Kelley W. N. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science. 1967 Mar 31;155(3770):1682–1684. doi: 10.1126/science.155.3770.1682. [DOI] [PubMed] [Google Scholar]
- Sperling O., Boer P., Persky-Brosh S., Kanarek E., De Vries A. Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):703–706. [PubMed] [Google Scholar]
- Sperling O., Persky-Brosh S., Boer P., De Vries A. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties. Biochem Med. 1973 Jun;7(3):389–395. doi: 10.1016/0006-2944(73)90059-8. [DOI] [PubMed] [Google Scholar]
- Switzer R. L. Regulation and mechanism of phosphoribosylpyrophosphate synthetase. 3. Kinetic studies of the reaction mechanism. J Biol Chem. 1971 Apr 25;246(8):2447–2458. [PubMed] [Google Scholar]
- Ullman B., Clift S. M., Cohen A., Gudas L. J., Levinson B. B., Wormsted M. A., Martin D. W., Jr Abnormal regulation of de novo purine synthesis and purine salvage in a cultured mouse T-cell lymphoma mutant partially deficient in adenylosuccinate synthetase. J Cell Physiol. 1979 Apr;99(1):139–151. doi: 10.1002/jcp.1040990115. [DOI] [PubMed] [Google Scholar]
- Ullman B., Cohen A., Martin D. W. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease. Cell. 1976 Oct;9(2):205–211. doi: 10.1016/0092-8674(76)90111-2. [DOI] [PubMed] [Google Scholar]
- Van der Weyden M. B., Kelly W. N. Human adenylosuccinate synthetase. Partial purification, kinetic and regulatory properties of the enzyme from placenta. J Biol Chem. 1974 Nov 25;249(22):7282–7289. [PubMed] [Google Scholar]
- WYNGAARDEN J. B., ASHTON D. M. The regulation of activity of phosphoribosyl-pyrophosphate amidotransferase by purine ribonacleotides: a potential feedback control of purine biosyntoesis. J Biol Chem. 1959 Jun;234(6):1492–1496. [PubMed] [Google Scholar]
- WYNGAARDEN J. B., GREENLAND R. A. The inhibition of succinoadenylate kinosynthetase of Escherichia coli by adenosine and guanosine 5'-monophosphates. J Biol Chem. 1963 Mar;238:1054–1057. [PubMed] [Google Scholar]